Search Query :
2X24
Bovine acc2 ct domain in complex with inhibitor Deposition Author(s): Blaho, S. , Folmer, R. , Hallberg, K. , Oster, L. , Wiberg, F.
Date: 2010-01-11 Method: X-RAY DIFFRACTION Resolution: 2.4 Å Organism(s): Bos Taurus Sequences Data: 2X24_A , 2X24_B
2YOP
Long wavelength s-sad structure of fam3b pander Deposition Author(s): Backstrom, S. , Bernstrom, J. , Gorman, T. , Holmberg Schiavone, L. , Johansson, P. , Oster, L. , Schweikart, F. , Xu, B. , Xue, Y.
Date: 2012-10-26 Method: X-RAY DIFFRACTION Resolution: 2.3 Å Organism(s): Mus Musculus Sequences Data: 2YOP_A , 2YOP_B , 2YOP_C
2YOQ
Structure of fam3b pander e30 construct Deposition Author(s): Backstrom, S. , Bernstrom, J. , Gorman, T. , Holmberg Schiavone, L. , Johansson, P. , Oster, L. , Schweikart, F. , Xu, B. , Xue, Y.
Date: 2012-10-26 Method: X-RAY DIFFRACTION Resolution: 2.35 Å Organism(s): Mus Musculus Sequences Data: 2YOQ_A , 2YOQ_B , 2YOQ_C
3BG8
Crystal structure of factor xia in complex with clavatadine a Deposition Author(s): Oster, L. , Xue, Y.
Date: 2007-11-26 Method: X-RAY DIFFRACTION Resolution: 1.6 Å Organism(s): Homo Sapiens Sequences Data: 3BG8_A
4CR5
Creating novel f1 inhibitors through fragment based lead generation and structure aided drug design Deposition Author(s): Akkaya, S. , Beisel, H.G. , Eriksson, P.O. , Erixon, K. , Fjellstrom, O. , Gustafsson, D. , Jurva, U. , Kang, D. , Karis, D. , Knecht, W. , Nerme, V. , Nilsson, I. , Olsson, T. , Oster, L. , Redzic, A. , Roth, R. , Sandmark, J. , Tigerstrom, A.
Date: 2014-02-25 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Homo Sapiens Sequences Data: 4CR5_A
4CR9
Creating novel f1 inhibitors through fragment based lead generation and structure aided drug design Deposition Author(s): Akkaya, S. , Beisel, H.G. , Eriksson, P.O. , Erixon, K. , Fjellstrom, O. , Gustafsson, D. , Jurva, U. , Kang, D. , Karis, D. , Knecht, W. , Nerme, V. , Nilsson, I. , Olsson, T. , Oster, L. , Redzic, A. , Roth, R. , Sandmark, J. , Tigerstrom, A.
Date: 2014-02-26 Method: X-RAY DIFFRACTION Resolution: 1.7 Å Organism(s): Homo Sapiens Sequences Data: 4CR9_A
4CRA
Creating novel f1 inhibitors through fragment based lead generation and structure aided drug design Deposition Author(s): Akkaya, S. , Beisel, H.G. , Eriksson, P.O. , Erixon, K. , Fjellstrom, O. , Gustafsson, D. , Jurva, U. , Kang, D. , Karis, D. , Knecht, W. , Nerme, V. , Nilsson, I. , Olsson, T. , Oster, L. , Redzic, A. , Roth, R. , Sandmark, J. , Tigerstrom, A.
Date: 2014-02-26 Method: X-RAY DIFFRACTION Resolution: 1.8 Å Organism(s): Homo Sapiens Sequences Data: 4CRA_A
4CRB
Creating novel f1 inhibitors through fragment based lead generation and structure aided drug design Deposition Author(s): Akkaya, S. , Beisel, H.G. , Eriksson, P.O. , Erixon, K. , Fjellstrom, O. , Gustafsson, D. , Jurva, U. , Kang, D. , Karis, D. , Knecht, W. , Nerme, V. , Nilsson, I. , Olsson, T. , Oster, L. , Redzic, A. , Roth, R. , Sandmark, J. , Tigerstrom, A.
Date: 2014-02-26 Method: X-RAY DIFFRACTION Resolution: 1.85 Å Organism(s): Homo Sapiens Sequences Data: 4CRB_A
4CRC
Creating novel f1 inhibitors through fragment based lead generation and structure aided drug design Deposition Author(s): Akkaya, S. , Beisel, H.G. , Eriksson, P.O. , Erixon, K. , Fjellstrom, O. , Gustafsson, D. , Jurva, U. , Kang, D. , Karis, D. , Knecht, W. , Nerme, V. , Nilsson, I. , Olsson, T. , Oster, L. , Redzic, A. , Roth, R. , Sandmark, J. , Tigerstrom, A.
Date: 2014-02-26 Method: X-RAY DIFFRACTION Resolution: 1.6 Å Organism(s): Homo Sapiens Sequences Data: 4CRC_A
4CRD
Creating novel f1 inhibitors through fragment based lead generation and structure aided drug design Deposition Author(s): Akkaya, S. , Beisel, H.G. , Eriksson, P.O. , Erixon, K. , Fjellstrom, O. , Gustafsson, D. , Jurva, U. , Kang, D. , Karis, D. , Knecht, W. , Nerme, V. , Nilsson, I. , Olsson, T. , Oster, L. , Redzic, A. , Roth, R. , Sandmark, J. , Tigerstrom, A.
Date: 2014-02-26 Method: X-RAY DIFFRACTION Resolution: 2.1 Å Organism(s): Homo Sapiens Sequences Data: 4CRD_A